Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $272,295 | $298,806 | $332,404 | $326,947 |
| - Cash | $114,518 | $112,459 | $122,154 | $129,290 |
| + Debt | $3,856 | $2,100 | $2,295 | $2,460 |
| Enterprise Value | $161,633 | $188,447 | $212,545 | $200,117 |
| Revenue | $156,006 | $141,706 | $128,330 | $120,193 |
| % Growth | 10.1% | 10.4% | 6.8% | – |
| Gross Profit | $91,196 | $78,971 | $72,700 | $70,067 |
| % Margin | 58.5% | 55.7% | 56.7% | 58.3% |
| EBITDA | $35,045 | $24,376 | $16,553 | $17,297 |
| % Margin | 22.5% | 17.2% | 12.9% | 14.4% |
| Net Income | $21,758 | $13,969 | $11,742 | $9,658 |
| % Margin | 13.9% | 9.9% | 9.1% | 8% |
| EPS Diluted | 295.15 | 181.42 | 147.87 | 118.84 |
| % Growth | 62.7% | 22.7% | 24.4% | – |
| Operating Cash Flow | $18,765 | $18,188 | $12,727 | $19,199 |
| Capital Expenditures | -$13,774 | -$13,036 | -$7,908 | -$4,193 |
| Free Cash Flow | $4,991 | $5,152 | $4,819 | $15,006 |